AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,977 | +24.6% | 79,804 | 0.0% | 0.00% | – |
| Q2 2023 | $73,021 | +63.3% | 79,804 | 0.0% | 0.00% | – |
| Q1 2023 | $44,722 | -41.4% | 79,804 | -39.7% | 0.00% | – |
| Q4 2022 | $76,377 | +81.8% | 132,370 | 0.0% | 0.00% | – |
| Q3 2022 | $42,000 | -87.8% | 132,370 | -72.2% | 0.00% | – |
| Q1 2022 | $343,000 | -65.8% | 476,974 | +7.4% | 0.00% | – |
| Q4 2021 | $1,004,000 | -21.5% | 443,958 | 0.0% | 0.00% | – |
| Q3 2021 | $1,279,000 | -69.4% | 443,958 | -59.7% | 0.00% | -100.0% |
| Q2 2021 | $4,178,000 | +21.6% | 1,102,209 | +8.6% | 0.00% | 0.0% |
| Q1 2021 | $3,436,000 | +28.4% | 1,014,934 | +6.2% | 0.00% | 0.0% |
| Q4 2020 | $2,677,000 | +13.1% | 956,009 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $2,366,000 | -83.4% | 942,376 | -10.0% | 0.00% | -85.7% |
| Q2 2020 | $14,218,000 | +152.6% | 1,046,924 | +41.0% | 0.01% | +133.3% |
| Q1 2020 | $5,629,000 | +22.2% | 742,612 | +1.9% | 0.00% | +50.0% |
| Q4 2019 | $4,605,000 | +67.3% | 728,621 | +3.8% | 0.00% | 0.0% |
| Q3 2019 | $2,753,000 | -12.3% | 702,056 | +8.2% | 0.00% | 0.0% |
| Q2 2019 | $3,140,000 | -32.4% | 648,753 | +14.4% | 0.00% | -33.3% |
| Q1 2019 | $4,644,000 | +49.9% | 566,940 | +1.2% | 0.00% | +50.0% |
| Q4 2018 | $3,099,000 | +0.4% | 560,260 | +60.2% | 0.00% | 0.0% |
| Q3 2018 | $3,088,000 | -19.1% | 349,622 | -8.6% | 0.00% | -33.3% |
| Q2 2018 | $3,818,000 | +15.7% | 382,512 | +10.5% | 0.00% | 0.0% |
| Q1 2018 | $3,299,000 | -25.1% | 346,121 | +16.9% | 0.00% | 0.0% |
| Q4 2017 | $4,404,000 | -6.1% | 296,131 | +24.3% | 0.00% | -25.0% |
| Q3 2017 | $4,689,000 | +58.0% | 238,333 | +15.4% | 0.00% | +33.3% |
| Q2 2017 | $2,968,000 | +157.6% | 206,476 | +65.0% | 0.00% | +200.0% |
| Q1 2017 | $1,152,000 | -6.1% | 125,130 | +6.2% | 0.00% | 0.0% |
| Q4 2016 | $1,227,000 | +22.0% | 117,777 | +6.0% | 0.00% | 0.0% |
| Q3 2016 | $1,006,000 | +27.5% | 111,155 | +5.4% | 0.00% | 0.0% |
| Q2 2016 | $789,000 | -15.6% | 105,433 | +1.7% | 0.00% | 0.0% |
| Q1 2016 | $935,000 | +13.3% | 103,669 | +62.5% | 0.00% | 0.0% |
| Q4 2015 | $825,000 | +37.3% | 63,812 | +2.6% | 0.00% | 0.0% |
| Q3 2015 | $601,000 | +30.7% | 62,187 | +39.2% | 0.00% | 0.0% |
| Q2 2015 | $460,000 | +97.4% | 44,680 | +113.8% | 0.00% | – |
| Q1 2015 | $233,000 | +73.9% | 20,895 | +81.7% | 0.00% | – |
| Q4 2014 | $134,000 | -64.3% | 11,500 | -32.0% | 0.00% | -100.0% |
| Q3 2014 | $375,000 | -18.8% | 16,919 | +1.8% | 0.00% | 0.0% |
| Q2 2014 | $462,000 | – | 16,613 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |